MEDICINE OVERVIEW OF Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

THERAPEUTIC CLASS OF Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

WHY Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge) IS PRESCRIBED

Substitutes for - Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

HOW IT WORKS

HOW TO TAKE

WHEN TO TAKE

Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge) Warnings

Precautions of Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

Contraindications of Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

Side Effects of Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

Alcohol Interaction

Food to Avoid

Pregnancy/Lactation Protocol

Storage of Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

Mixtard 30 HM Penfill 100 IU Injection 3 ml Cartridge (5 Cartridge)

Manufactured By: Abbott India Limited(Novo Nordisk)
Composition/Salt

Biphasic Isophane Insulin
human Insulin (30% As Soluble Insulin And 70% As Isophane Insulin) 100IU/ml

About Mixtard 30 HM Penfill 100 IU Injection :

Mixtard 30 HM Penfill 100 IU Injection is a unique mixture of both fast-acting insulin and long-acting insulin. Each ml suspension of Mixtard 30 HM Penfill 100 IU Injection contains Human Insulin 100 IU (30% as soluble insulin and 70% as isophane insulin), Metacresol USP 1.5mg and Phenol IP 0.065 mg (as preservative) and Water for injection IP q.s.and excipients q.s.

Mixtard 30 HM Penfill 100 IU Injection is a dual-acting human insulin used to treat diabetes. 1 ml of suspension contains 100 international units of soluble insulin and isophane (NPH) insulin in the ratio of 30/70 (equivalent to 3.5 mg).

Use of Mixtard 30 HM Penfill 100 IU Injection :

Mixtard 30 HM Penfill 100 IU Injection is indicated for patients with Diabetes Mellitus. Mixtard 30 HM Penfill 100 IU Injection may be used for Type 1 or Type 2 Diabetes.

Usage Direction of Mixtard 30 HM Penfill :

  • Doctor will advise the right dose & duration of administration of Mixtard 30 HM Penfill  100 IU Injection as per the patient’s condition.
  • Generally Mixtard 30 HM Penfill  100 IU Injection is administered subcutaneously into the thigh, upper arm or abdomen.
  • Rotate the injection site to reduce risk of lipodystophy and localized cutaneous amyloidosis.
  • Mixtard 30 HM Penfill 100 IU Injection is designed to be used with Novo Nordisk insulin delivery systems and Novo Fine disposable needles.
  • Do not use your Penfill if any damage is seen or if there is a gap between the plunger and the white label band.
  • For proper usage direction please follow the instructions of the package insert.

Precaution & Related Information of Mixtard 30 HM Penfill 100 IU Injection :

  • Mixtard 30 HM Penfill 100 IU Injection should not be shared between patients, even if the needles are changed.
  • If patient is on any other medications or facing any complication during usage please inform your physician or health care provider.
  • Please take precautions during the use of the Mixtard 30 HM Penfill  100 IU Injection in case of hyperglycemia, hypoglycemia.
  • Pregnancy & lactation: During pregnancy & lactation please consult with your physician. Study shows there are no restrictions on treatment of diabetes with insulin during pregnancy, as insulin does not pass the placental barrier. There is no restriction on treatment with Mixtard 30 HM Penfill 100 IU Injection during breast-feeding. Insulin treatment of the nursing mother presents no risk to the baby.
  • Keep the cartridge in the outer carton in order to protect from light.
  • Before opening: Store in a refrigerator (2°C – 8°C). Do not freeze.
  • During use or when carried as a spare: Store below 30°C. Do not refrigerate or freeze.

Loading

Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics and information, contained on or available through this website is for general information purposes only. SastaSundar.com makes no representation and assumes no responsibility for the accuracy of information contained on or available through this website and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources and review all information regarding any medical condition or treatment with your physician. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEBSITE.

SastaSundar.com does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, procedures, treatments, opinions or other information that may be contained on or available through this website.